Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 27, 2022

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2026

Conditions

ChordomaMetastatic ChordomaUnresectable Chordoma

Interventions

BIOLOGICAL

Cetuximab

Given IV

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors

lead

M.D. Anderson Cancer Center

OTHER